The performance of companies tied to the drug's legacy presents a complex investment landscape. While the initial boom generated substantial returns , generic copies have significantly diminished market share https://xyzbookmarks.com/story21441808/copyright-s-flagship-product-and-pharma-a-speculative-opportunity